As of 2024-12-11, the Intrinsic Value of HBM Healthcare Investments AG (HBMN.SW) is
105.48 CHF. This HBMN.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 184.40 CHF, the upside of HBM Healthcare Investments AG is
-42.80%.
The range of the Intrinsic Value is 62.22 - 292.97 CHF
105.48 CHF
Intrinsic Value
HBMN.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
62.22 - 292.97 |
105.48 |
-42.8% |
| DCF (Growth 10y) |
66.57 - 284.59 |
107.80 |
-41.5% |
| DCF (EBITDA 5y) |
25.77 - 36.17 |
29.64 |
-83.9% |
| DCF (EBITDA 10y) |
37.45 - 52.26 |
43.34 |
-76.5% |
| Fair Value |
329.67 - 329.67 |
329.67 |
78.78% |
| P/E |
14.02 - 143.47 |
72.48 |
-60.7% |
| EV/EBITDA |
26.59 - 83.35 |
54.04 |
-70.7% |
| EPV |
(95.76) - (144.89) |
(120.33) |
-165.3% |
| DDM - Stable |
147.49 - 810.59 |
479.04 |
159.8% |
| DDM - Multi |
18.38 - 74.60 |
29.05 |
-84.2% |
HBMN.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,283.42 |
| Beta |
0.88 |
| Outstanding shares (mil) |
6.96 |
| Enterprise Value (mil) |
1,378.16 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.86% |
| Cost of Debt |
4.25% |
| WACC |
5.69% |